Is NCT03703505 results overdue?

Yes — results are overdue. Primary completion was 2018-06-01; the FDAAA-801 reporting deadline (2019-06-01) passed 2623 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348

NCT ID	NCT03703505 ↗
Sponsor	Agios Pharmaceuticals, Inc. (INDUSTRY)
Public issuer	AGIOS PHARMACEUTICALS, INC. — AGIO (CIK 0001439222) best-effort name match, 95% conf — verify on EDGAR ↗
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-06-01 (ACTUAL)
Reporting deadline	2019-06-01 (completion + 365d)
Days overdue	2623
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `f734db3d199ea6ff…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03703505. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.